1. Home
  2. AYTU vs JVA Comparison

AYTU vs JVA Comparison

Compare AYTU & JVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AYTU
  • JVA
  • Stock Information
  • Founded
  • AYTU N/A
  • JVA 1971
  • Country
  • AYTU United States
  • JVA United States
  • Employees
  • AYTU N/A
  • JVA N/A
  • Industry
  • AYTU Biotechnology: Pharmaceutical Preparations
  • JVA Packaged Foods
  • Sector
  • AYTU Health Care
  • JVA Consumer Staples
  • Exchange
  • AYTU Nasdaq
  • JVA Nasdaq
  • Market Cap
  • AYTU 15.0M
  • JVA 14.7M
  • IPO Year
  • AYTU N/A
  • JVA 2005
  • Fundamental
  • Price
  • AYTU $2.24
  • JVA $3.14
  • Analyst Decision
  • AYTU
  • JVA
  • Analyst Count
  • AYTU 0
  • JVA 0
  • Target Price
  • AYTU N/A
  • JVA N/A
  • AVG Volume (30 Days)
  • AYTU 32.2K
  • JVA 182.8K
  • Earning Date
  • AYTU 11-12-2024
  • JVA 10-18-2024
  • Dividend Yield
  • AYTU N/A
  • JVA N/A
  • EPS Growth
  • AYTU N/A
  • JVA N/A
  • EPS
  • AYTU N/A
  • JVA 0.20
  • Revenue
  • AYTU $81,002,000.00
  • JVA $76,111,698.00
  • Revenue This Year
  • AYTU N/A
  • JVA N/A
  • Revenue Next Year
  • AYTU N/A
  • JVA N/A
  • P/E Ratio
  • AYTU N/A
  • JVA $15.94
  • Revenue Growth
  • AYTU N/A
  • JVA 17.27
  • 52 Week Low
  • AYTU $2.11
  • JVA $0.67
  • 52 Week High
  • AYTU $3.50
  • JVA $3.88
  • Technical
  • Relative Strength Index (RSI)
  • AYTU 40.89
  • JVA 57.55
  • Support Level
  • AYTU $2.11
  • JVA $2.69
  • Resistance Level
  • AYTU $2.44
  • JVA $3.09
  • Average True Range (ATR)
  • AYTU 0.14
  • JVA 0.24
  • MACD
  • AYTU -0.02
  • JVA -0.05
  • Stochastic Oscillator
  • AYTU 17.57
  • JVA 42.86

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complimentary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. AR101/enzastaurin has received Orphan Drug designation from the FDA. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which it generates maximum revenue from the Rx segment.

About JVA Coffee Holding Co. Inc.

Coffee Holding Co Inc is engaged in the business of wholesale coffee operations, including manufacturing, roasting, packaging, marketing and distributing roasted and blended coffees for private labeled accounts and its own brands, and it sells green coffee. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada and certain countries in Asia.

Share on Social Networks: